Patent details

Basic Information

Publication number:

EP2146997

PCT Application Number:

PCT/US/2008/004533

Type:

European Patent Granted for LU

Legal Status:

Lapsed

Application number:

EP087426474

PCT Publication Number:

WO/2008/127585

First applicant's nationality:

Translation Language:

EPO Publication Language:

English

English Title of Invention:

SUBSTITUTED FUROÖ2,3-BÜPYRIDINE DERIVATIVES AS CANNABINOID-1 RECEPTOR MODULATORS

French Title of Invention:

DÉRIVÉS FUROÖ2,3-BÜPYRIDINE SUBSTITUÉS UTILES EN TANT QUE MODULATEURS DU RÉCEPTEUR DES CANNABINOÏDES 1

German Title of Invention:

SUBSTITUIERTE FUROÖ2,3-BÜPYRIDINDERIVATE ALS CANNABINOID-1-REZEPTORMODULATOREN

SPC Number:

Dates

Filing date:

07/04/2008

Grant date:

10/11/2010

EP Publication Date:

10/11/2010

PCT Publication Date:

23/10/2008

Claims Translation Received Date:

Translations Received Date (B1 EP Publication):

Translations Received Date (B2 EP Publication):

Translations Received Date (B3 EP Publication):

Publication date:

27/01/2010

EP B1 Publication Date:

10/11/2010

EP B2 Publication Date:

EP B3 Publication Date:

Lapsed date:

07/04/2011

Expiration date:

07/04/2028

Renunciation date:

Revocation date:

Annulment date:

Owner

From:

07/04/2008

 

 

Name:

Merck Sharp & Dohme Corp.

Address:

126 East Lincoln Avenue, 07065-0907, Rahway, NJ, United States (US)

Inventor

1

Name:

CLEMENTS Matthew, J.

Address:

United States (US)

2

Name:

HELMY Roy

Address:

United States (US)

3

Name:

PERESYPKIN Andrey, V.

Address:

United States (US)

4

Name:

DEBENHAM John, S.

Address:

United States (US)

5

Name:

HALE Jeffrey, J.

Address:

United States (US)

6

Name:

WALSH Thomas, F.

Address:

United States (US)

7

Name:

MADSEN-DUGGAN Christina, B.

Address:

United States (US)

Priority

Priority Number:

922851 P

Priority Date:

11/04/2007

Priority Country:

United States (US)

Classification

Main IPC Class:

C07D 491/048;

Filing date	Document type	Number of pages